FDA Approves Roche’s Enspryng as First At-Home Injectable Treatment for Thyroid Eye Disease
As reported on PharmaBiz, the US Food and Drug Administration (FDA) has approved Roche’s Enspryng (satralizumab) for the treatment of adults with thyroid eye disease (TED), introducing the first subcutaneous…